Crescent Biopharma, Inc.CBIONASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+64.5%
5Y CAGR+9.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+64.5%/yr
vs -30.9%/yr prior
5Y CAGR
+9.2%/yr
Recent acceleration
Acceleration
+95.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $213.19M | +513.2% |
| 2024 | $34.77M | -16.8% |
| 2023 | $41.79M | -12.7% |
| 2022 | $47.87M | -47.0% |
| 2021 | $90.25M | -34.1% |
| 2020 | $137.04M | -13.4% |
| 2019 | $158.20M | -24.6% |
| 2018 | $209.92M | +69.4% |
| 2017 | $123.92M | +209.5% |
| 2016 | $40.04M | - |